David Saceda-Corralo Selected Research

Alopecia (Baldness)

7/2022	Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
1/2022	Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
1/2022	Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study.
1/2022	Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata.
11/2021	Post-chemotherapy alopecia: what the dermatologist needs to know.
6/2021	Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
5/2021	Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice.
1/2021	Comment on "Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series": Adding further evidence about side effects.
1/2021	Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss.
11/2020	Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Saceda-Corralo Research Topics

Disease

20	Alopecia (Baldness) 07/2022 - 05/2016
3	Folliculitis (Sycosis) 01/2022 - 11/2018
3	Lichen Planus (Lichen Ruber Planus) 10/2021 - 01/2018
2	Edema (Dropsy) 01/2022 - 06/2021
2	Alopecia Areata 01/2022 - 05/2016
2	Headache (Headaches) 01/2022 - 06/2021
2	Actinic Keratosis 11/2018 - 10/2016
1	Contact Dermatitis (Eczema, Contact) 01/2022
1	Erythema 01/2022
1	Burnett Schwartz Berberian syndrome 12/2021
1	Neoplasms (Cancer) 11/2021
1	Tachycardia (Tachyarrhythmias) 06/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2021
1	Dizziness (Lightheadedness) 06/2021
1	Hypertrichosis 01/2021
1	Pulmonary Arterial Hypertension 11/2020
1	Skin Diseases (Skin Disease) 11/2020
1	Rosacea (Acne Rosacea) 11/2020
1	Exanthema (Rash) 07/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Gynecomastia 01/2020
1	Erectile Dysfunction 01/2020
1	Cellulitis 08/2019
1	Acne Keloid (Acne Keloidalis) 08/2019
1	Pain (Aches) 06/2017
1	Skin Neoplasms (Skin Cancer) 10/2016
1	Bowen's Disease (Disease, Bowen) 10/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016

Drug/Important Bio-Agent (IBA)

9	Minoxidil (Rogaine)FDA LinkGeneric 01/2022 - 01/2019
4	Dutasteride (Avodart)FDA Link 07/2022 - 07/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
2	bicalutamide (Casodex)FDA LinkGeneric 11/2020 - 11/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2017 - 10/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	diphenylcyclopropenoneIBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Dapsone FDA Link 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	SaltsIBA 01/2022
1	nilotinib FDA Link 12/2021
1	avelumabIBA 10/2021
1	AfatinibIBA 11/2020
1	selexipagIBA 11/2020
1	ErbB Receptors (EGF Receptor)IBA 07/2020
1	Lenalidomide (CC 5013)FDA Link 07/2020
1	Diclofenac (SR 38)FDA LinkGeneric 11/2018
1	Hyaluronic Acid (Hyaluronan)IBA 11/2018
1	SteroidsIBA 11/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016
1	Azathioprine (Imuran)FDA LinkGeneric 05/2016

Therapy/Procedure

5	Therapeutics 11/2021 - 05/2016
3	Mesotherapy 07/2022 - 07/2017
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 11/2021
1	Radiotherapy 11/2020
1	Traction 08/2019
1	Low-Level Light Therapy (LLLT) 01/2018